COMPARING PALIVIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMODYNAMICALLY SIGNIFICANT CONGENITAL HEART DISEASE (HSCHD) IN THE CARESS DATABASE (2005-2015) IN THE FIRST VERSUS SECOND YEAR OF LIFE Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

publication date

  • November 1, 2016